Each amount stays with its study
CJC-1295 Ipamorelin dosage: which amounts were studied?
People, mice, and rats received different amounts. No human study chose an amount for the two drugs together.
Which drug amounts have studies actually measured?
No human amount was set for CJC-1295 Ipamorelin. These figures record research, not your personal plan.
Each figure belongs to certain test subjects. How researchers gave the drug also matters.
Healthy adults received 30 to 90 micrograms per kilogram beneath the skin [1]. They received long CJC-1295 with DAC, an added part that binds to blood protein.
Almost all recorded ipamorelin amounts came from animal work. Above 1 microgram per kilogram, rodents had little more growth-hormone rise.
The long form was found in blood across several days. The short form cleared after roughly half an hour.
Ipamorelin lasts a few hours in animals. No human trial chose an amount for CJC-1295 with ipamorelin.
Which studies supplied the Cjc 1295 ipamorelin dosage figures?
Each figure belongs to a separate test. None is a personal plan.
Long CJC-1295 with DAC. DAC is an added part that binds the drug to blood protein.
Phase 1 means an early human safety test. People received 30 to 90 micrograms per kilogram beneath the skin [1].
Mice received about 2 micrograms per day. A mouse amount doesn't become a human amount.
Short CJC-1295 without DAC. No full human study tested the short form alone.
Some proposed plans listed 100 to 200 micrograms in each test shot. The plans don't show that anyone received those shots.
Ipamorelin. A rat bone study gave 100 micrograms three times daily for every kilogram.
Researchers were checking for new bone growth. That result gives no amount for a person.
Another animal study gave 0.5 milligrams each day for every kilogram. A bowel study put 0.01 to 1 milligrams into an animal's vein for each kilogram.
In rodents, the hormone rise changed little near 1 microgram per kilogram. Researchers haven't published a tested amount for people.
No study tested CJC-1295 and ipamorelin as one mix. No paper gives an amount for the pair [1][2].
That gap matters to you. Animal amounts can't fill it.
How long did each drug form stay in the body?
CJC-1295 comes in long and short forms. The human study found the long form lasted about six to eight days.
The long form has DAC, an added part that binds to blood protein. Rat blood still held the bound drug after 72 hours [1][5].
CJC-1295 without that part is called Mod GRF (1-29). The body clears this short form after about 30 minutes.
Ipamorelin left rodents within about two hours. Their blood had the most growth hormone near 40 minutes [2].
No sound paper gives ipamorelin's time in human blood. That missing fact limits any safety claim.
Long and short CJC-1295 expose the body for different times. Older pairing studies measured brief hormone bursts [3].
A 30-minute form doesn't act like one lasting days. A fair label must say which form it contains.
The form name belongs beside each study result. Without the name, you can't know how long the drug acted.
Why does Mod grf 1-29, the short form, leave blood so soon?
Mod GRF (1-29) means CJC-1295 without the added binding part. Researchers changed parts of its 29-amino-acid chain, made from small protein links.
Those changes slow some breakdown in blood. The number describes the chain, not an amount for you.
The short form still can't bind to blood protein like the long form. Your body therefore clears the short form much sooner.
The short form copies one natural hormone burst. The long form can extend growth-hormone release across days.
A label saying only "CJC-1295" leaves the form unclear. The two forms don't keep your body exposed for the same time [5].
How did studies give and handle each drug?
Some study shots went beneath the skin; others went into a vein. Rodent tests also used pumps or the nose.
The lab powder was freeze-dried, meaning its water was removed while cold. Cold storage slowed breakdown after sterile water was added.
Shaking and repeat freezing can damage a peptide, which is a short protein chain. These lab facts aren't steps for a human shot.
Long CJC-1295 reached Phase 2, which checks benefit and harm in more people. Reaching that stage does not mean approval.
A serious health problem occurred in one person, and the work ended. A public report denied a drug link but didn't explain the end, so the reason remains unclear [1].
Public records name a second Phase 2 test but give no result. Ipamorelin was also studied after bowel surgery.
Those surgery studies asked whether bowel movement returned sooner. Approval for ipamorelin did not follow.
No human study tested an amount for the pair. The right amount remains unknown.